(0.92%) 5 094.70 points
(0.35%) 38 221 points
(1.75%) 15 885 points
(0.54%) $84.02
(-2.99%) $1.589
(0.41%) $2 352.00
(0.46%) $27.48
(0.33%) $923.50
(0.26%) $0.934
(0.55%) $11.01
(0.09%) $0.800
(-0.65%) $91.57
Live Chart Being Loaded With Signals
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health...
Stats | |
---|---|
Today's Volume | 130 997 |
Average Volume | 340 628 |
Market Cap | 1.64B |
EPS | €-0.220 ( 2023-09-30 ) |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -15.93 |
ATR14 | €0.0310 (0.34%) |
Volume Correlation
Evotec SE Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Evotec SE Correlation - Currency/Commodity
Evotec SE Financials
Annual | 2022 |
Revenue: | €751.45M |
Gross Profit: | €174.07M (23.16 %) |
EPS: | €-0.990 |
FY | 2022 |
Revenue: | €751.45M |
Gross Profit: | €174.07M (23.16 %) |
EPS: | €-0.990 |
FY | 2021 |
Revenue: | €618.03M |
Gross Profit: | €151.54M (24.52 %) |
EPS: | €1.300 |
FY | 2020 |
Revenue: | €500.92M |
Gross Profit: | €125.74M (25.10 %) |
EPS: | €0.0400 |
Financial Reports:
No articles found.
Evotec SE
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators